Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery
ClinicalTrials.gov study NCT01292083. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Study Comparing Paclitaxel Plus Carboplatin Versus Anthracyclines Followed by Docetaxel as Adjuvant Chemotherapy for Triple Negative Breast Cancer (PATTERN)
ClinicalTrials.gov study NCT04031703. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Camrelizumab, Pirfenidone, and Chemotherapy in the Treatment of Advanced Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT07161791. IPD Sharing: NO. Countries: 0. Publications: 0.
Psychological Factors and Oncological Outcomes of Triple-negative Breast Cancer
ClinicalTrials.gov study NCT04669522. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple Negative Breast Cancer
ClinicalTrials.gov study NCT02627430. IPD Sharing: Not stated. Countries: 0. Publications: 0.
The Combination of Palbociclib With ddEC-P as Neoadjuvant Therapy in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03756090. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
JK-1201I in Triple Negative Breast Cancer Patients with Brain Metastases
ClinicalTrials.gov study NCT06586866. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Neoadjuvant Goserelin for Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03444025. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Neoadjuvant Therapy With Ivonescimab Combined With Chemotherapy for Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT06977542. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Pilot Study of Glembatumumab Vedotin Following Doxorubicin and Cytoxan as Neo-adjuvant Therapy in Gp-NMB-expressing High Risk Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03473691. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer
ClinicalTrials.gov study NCT02685306. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
To Evaluate the Efficacy of Toripalimab Combined With Chemotherapy After HIFU Induction in the Treatment of Early Triple-negative Breast Cancer
ClinicalTrials.gov study NCT05491694. IPD Sharing: Not stated. Countries: 0. Publications: 0.
SHR-1210 Combined With Albumin-bound Paclitaxel and Epirubicin Neoadjuvant for Triple Negative Breast Cancer
ClinicalTrials.gov study NCT04213898. IPD Sharing: Not stated. Countries: 0. Publications: 0.
SHR-A2102 Combined With Adebrelimab as Neoadjuvant Therapy for Early Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT06819319. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)
ClinicalTrials.gov study NCT05255666. IPD Sharing: NO. Countries: 0. Publications: 0.
Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT04249167. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Efficacy of Interleukin-2 in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT05821686. IPD Sharing: NO. Countries: 0. Publications: 0.
Evaluating Bemotuzumab to Improve the Efficacy of Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT06975644. IPD Sharing: NO. Countries: 0. Publications: 0.
ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian Cancer
ClinicalTrials.gov study NCT05368506. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Association of Pembrolizumab Infusion Time and Efficacy in Patients With Non-metastatic Triple-negative Breast Cancer (TNBC) Treated With Neoadjuvant Chemotherapy and Immunotherapy
ClinicalTrials.gov study NCT06418139. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.